Category: Cost Alert

The Unanswered Question of High-Cost Drugs

More than three-quarters of the public say more needs to be done to make high-priced prescription drugs more affordable for those who need them, according to a new Kaiser Family Foundation poll. Recent reports demonstrate those concerns are warranted: Continue reading

Posted in: Cost Alert, Health Care Costs

One drug, one state, a $286 million cost

Here’s a frightening statistic from Capital New York: Last year Medicare spent the same amount on one hepatitis C drug in one state as it spent on all hep C medications across all 50 states in 2013. Continue reading

Posted in: Cost Alert

Are identical treatments worth 834% more?

Health plans work hard to ensure access to safe, effective treatments. But those efforts are undermined by drug manufacturers charging Americans the highest prices in the world for the exact same brand name drugs. The practice of charging different customers different prices for identical products (think airlines or hotels), commonly referred to by economists as “price discrimination,” raises serious concerns when it impacts American consumers who need to access prescribed treatments. Continue reading

Posted in: Cost Alert

Drug Prices: A Threat to Innovation

New drugs are hitting the market, offering patients additional treatment options. But many experts are concerned that the exorbitant prices of these medications will jeopardize medical innovation as we know it. Continue reading

Posted in: Cost Alert, Health Care Costs

The charts that drugmakers don’t want you to see

Why are patients paying more for health care? Exhibit A: It’s the drug prices, which jumped more than 6 percent in the last year. Continue reading

Posted in: Cost Alert, Health Care Costs

INFOGRAPHIC: The cost of prescription drugs then and now

Despite the introduction of new, and in many cases more innovative medical treatments, prescription drugs that have been around for years continue to get more and more expensive. Continue reading

Posted in: Cost Alert, Health Care Costs, Infographic

AHIP statement on Harvoni

America’s Health Insurance Plans (AHIP) Spokesman Brendan Buck released the following statement today after Gilead Sciences announced its newly approved hepatitis C drug Harvoni will be priced at $94,500 for a course of treatment. Continue reading

Posted in: Cost Alert, Health Care Costs

Moment of Truth: Gilead Comes to a Pricing Decision Point

The eyes of the health care world – and prime time TV audiences – are focused this week on the high prices of many pharmaceutical drugs. And one looming decision will tell us whether the tide has turned in favor of sustainable pricing – or whether drugmakers still have their heads in the sand. Continue reading

Posted in: Cost Alert, Health Care Costs

Consumer Reports: What’s to blame for soaring health care costs

Consumers are angry over outrageous sky-high health care costs, and rightfully so. But what’s to blame for this health care cost outrage? Consumer Reports gives us some answers. Continue reading

Posted in: Cost Alert

Chart of the day: Anger at outrageous health care costs

Health care costs are increasing at unsustainable and unaffordable rates, and consumers are sounding the alarm. They’re fed up with the soaring prices for medical services, as evidenced by a recent Consumer Reports survey that’s aptly titled The Anger Index. Continue reading

Posted in: Cost Alert, Health Care Costs